1125 related articles for article (PubMed ID: 25480417)
21. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract][Full Text] [Related]
22. Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma.
Wang L; Cai Y; Zhao X; Jia X; Zhang J; Liu J; Zhen H; Wang T; Tang X; Liu Y; Wang J
Neoplasma; 2015; 62(3):412-8. PubMed ID: 25866221
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
24. Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.
Sun C; Zhou Z; Shi H; Li F; Zhang G
Dis Markers; 2019; 2019():2814058. PubMed ID: 31871500
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Wang LN; Zhu XQ; Song XS; Xu Y
J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.
Lei B; Xu SP; Liang XS; Li YW; Zhang JF; Zhang GQ; Pang D
Tumour Biol; 2016 Apr; 37(4):5257-64. PubMed ID: 26555546
[TBL] [Abstract][Full Text] [Related]
29. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
Liu M; Sun W; Liu Y; Dong X
Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of overexpressed long non-coding RNA TUG1 in patients with clear cell renal cell carcinoma.
Wang PQ; Wu YX; Zhong XD; Liu B; Qiao G
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):82-86. PubMed ID: 28121352
[TBL] [Abstract][Full Text] [Related]
31. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
32. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma.
Xiong J; Liu Y; Jiang L; Zeng Y; Tang W
Jpn J Clin Oncol; 2016 Apr; 46(4):378-84. PubMed ID: 26848077
[TBL] [Abstract][Full Text] [Related]
33. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
34. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
[TBL] [Abstract][Full Text] [Related]
36. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
[TBL] [Abstract][Full Text] [Related]
37. Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Su H; Sun T; Wang H; Shi G; Zhang H; Sun F; Ye D
Oncotarget; 2017 Jan; 8(4):5789-5799. PubMed ID: 27494890
[TBL] [Abstract][Full Text] [Related]
38. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.
Ding C; Han F; Xiang H; Xia X; Wang Y; Dou M; Zheng J; Li Y; Xue W; Ding X; Tian P
J Cell Biochem; 2018 Dec; 119(12):10406-10414. PubMed ID: 30129055
[TBL] [Abstract][Full Text] [Related]
39. MALAT1 promoted invasiveness of gastric adenocarcinoma.
Lee NK; Lee JH; Ivan C; Ling H; Zhang X; Park CH; Calin GA; Lee SK
BMC Cancer; 2017 Jan; 17(1):46. PubMed ID: 28077118
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
Cao Q; Ruan H; Wang K; Song Z; Bao L; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Liu D; Yang H; Chen K; Zhang X
Int J Oncol; 2018 Jul; 53(1):137-147. PubMed ID: 29749470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
